Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities

Business Insights
April 1, 2009
208 Pages - Pub ID: RET2200140
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Related Reports


The Autoimmune Market Outlook to 2013 provides comprehensive coverage of the autoimmune market, incorporating disease overviews and detailed epidemiological analyses for the major indications. This report makes a comprehensive assessment of the marketed product portfolio, R&D pipeline, market share data, sales forecast and the competitive landscape for the major players. Further, this report highlights the key market and R&D trends that may influence drug sales, with a thorough analysis of the competitive dynamics of leading brands within each indication to enable you to identify growth brands, key drug classes and leading players through to 2013.

Related Reports:
Prostate Cancer Drug Discoveries: What the Future Holds
BI for Drug Development: Oracle Introduces Clinical Development Analytics
Competitor Analysis: TGF-R Agonists and Antagonists
China Pharma Outsourcing Annual Review 2009
Competitor Analysis: FGF-R Agonists and Antagonists
Canada's Pharmaceutical Industry - Porter’s Five Forces Strategy Analysis
Asia Pacific Pharma Sector Analysis
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors
Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)

Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 4